/ /

CLINICAL

Endocryotherapy shows potential for hemangioblastoma
Endocryotherapy shows potential for hemangioblastomaEndocryotherapy is a good treatment option for patients with larger retinal angiomatous tumors.
NRTIs hold promise for preventing or treating AMDNucleoside-reverse, transcriptase inhibitors (NRTIs) or their derivatives could one day be used to prevent or treat age-related macular degeneration (AMD), according to Jayakrishna Ambati, MD.
Presbyopic IOLs changing game for astigmatic patientsPresbyopia-correcting IOLs are changing the preoperative patient education discussion, making it easier for surgeons. However, the need for precision measurements and careful surgical technique may be more important than in the past.
New products, advancements in dry eyeDavid Kading, OD, FAAO, FCLSA, discusses new products, studies, and patient education available to help combat dry eye disease.
Preparing your patient for PRKPhotorefractive keratectomy (PRK) was the original excimer laser procedure approved by the FDA—and is still a safe and effective treatment of refractive errors. PRK has the benefits of no-flap creation; therefore, there is no risk of flap complications.
Portable imaging system captures quality images
Portable imaging system captures quality imagesNew technology has been paired with the time-tested technique of direct ophthalmoscopy to create a portable, retinal imaging system (D-Eye, D-Eye S.r.l.) that utilizes a small optical device magnetically attached to a smartphone
Multiple strategies pursue treatment of dry AMDThere are a number of ongoing clinical trials investigating treatments for dry age-related macular degeneration (AMD). These modalities include medications that are already in use for other indications and investigational agents representing various novel mechanisms of action.
Algorithm could change way to treat wet AMDAn algorithm for guiding clinical judgments about the futility of anti-VEGF treatment of neovascular age-related macular degeneration (nvAMD) has importance from clinical, ethical, and legal perspectives and would be a valuable decision-making tool for retina specialists and payors, according to David T. Wong, MD.
Growing attention turns to cerebrospinal fluid pressure in glaucomaCataract surgery in patients with coexisting uveitis is more challenging than managing either condition alone.
Securing grafts without suturesGlaucoma drainage devices aid in controlling IOP by redirecting aqueous from the anterior chamber to an external reservoir to regulate flow. They are typically used for patients who have failed previous surgeries or who have a high likelihood of failing procedures, such as trabeculectomy. While effective, they are traditionally anchored through the use of sutures, which is both time-intensive and may cause complications.